Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

eBioMedicine, 2026
Multi-omics analysis of the gut microbiome and carotid artery atherosclerosis in men with and without HIV

Wang Z., Wang Y., Peters B. et al.

Olink Explore 3072/384CVDInfectious DiseasesPathophysiologyPlasma

Translational Oncology, 2026
Clinical validation of PEA-driven Olink proteomic discovery: INPP1 and ARHGAP25 serum biomarkers improve early breast cancer diagnosis

Huang J., Gao L., Glazutdinova L. et al.

Olink Explore 3072/384OncologyPatient StratificationSerum

Journal of Clinical & Translational Endocrinology, 2026
Increased cytokine production capacity and persistent inflammation after achieving remission of Cushing’s syndrome

van Houten P., van de Ven A., van Herwaarden A. et al.

Olink Target 96EndocrinologyPathophysiologyPlasma

npj Digital Medicine, 2026
Leveraging population-scale proteomic data with deep learning for head and neck cancer detection in saliva

Shakeel A., Merriel S., Smith J. et al.

Olink Target 96Olink Explore 3072/384OncologyWider Bioinformatics StudiesTechnical EvaluationData SciencePlasmaSaliva

ERJ Open Research, 2026
Proteome-wide Mendelian randomisation of lung function to identify potential therapeutic targets for respiratory disease

Chen J., Shrine N., Coley K. et al.

Olink Explore 3072/384Respiratory DiseasesPathophysiologyPlasma

Blood Cancer Journal, 2026
A differentiated effector T cell repertoire defines a functionally high-risk group of smoldering myeloma patients

Firestone R., Simhal A., Akhlaghi T. et al.

Olink Target 96OncologyPatient StratificationPlasma

Atherosclerosis, 2026
Inflammation may explain part of atherosclerotic cardiovascular disease risk conferred by elevated remnant lipoproteins: a cohort and Mendelian randomization study

Wadström B., Wulff A., Pedersen K. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

JHEP Reports, 2026
Hepatic flares, their immune signatures, and ALT variability after nucleos(t)ide analogue cessation in HBeAg-negative hepatitis B

Holmberg M., Niehrs A., Dalgard O. et al.

Olink Target 96HepatologyPathophysiologySerum

eBioMedicine, 2026
A randomized, observer-blind, phase 1 study of immune responses to three human adenovirus type 26 vector–based vaccines

Hertoghs N., Serroyen J., Tolboom J. et al.

Olink Explore 3072/384Olink Target 48Immunological & Inflammatory DiseasesPathophysiologyPlasma

Archives of Medical Science, 2026
Deciphering the Interplay Between Inflammatory Factors and Brain Structural Features in Epilepsy

Fang S., Dong X., Li X. et al.

Olink Target 96NeurologyPathophysiologyPlasma

Neurobiology of Disease, 2026
Machine learning based multi-omics analysis reveals key molecular determinants of Parkinson's disease severity

Jin H., Meng L., Yulug B. et al.

Olink Explore 3072/384NeurologyPatient StratificationPlasma

Neurobiology of Disease, 2026
A NETs-centric multi-omics framework prioritizes PGLYRP1 and MMP9 as subtype-associated thromboinflammatory biomarker candidates and putative therapeutic hypotheses in ischemic stroke

Tan H., Gong H., Li H. et al.

Olink Target 96CVDNeurologyPathophysiologyPlasma

Lung Cancer, 2026
A dynamic proteomic signature for the prediction of lung Cancer: a longitudinal analysis in the UK Biobank cohort

Liang J., Feng Y., Gui D. et al.

Olink Explore 3072/384OncologyPathophysiologyPatient StratificationPlasma

Journal of Infection, 2026
Early antiretroviral therapy shapes the immunometabolic landscape without reducing the intact HIV reservoir

Suanzes P., Grau-Expósito J., Navarro J. et al.

Olink Target 48Infectious DiseasesPathophysiologyPlasma

Nature Biotechnology, 2026
mRNA vaccine immunity is enhanced by hepatocyte detargeting and not dependent on dendritic cell expression

Marks A., Siu S., Bianchini F. et al.

Olink Target 96 MouseImmunological & Inflammatory DiseasesPathophysiologyMouse Cell Culture Supernatant

Nature Genetics, 2026
Multi-ancestry genome-wide association and integrated multi-omics analyses of endometriosis and its clinical manifestations

Koller D., He J., Løkhammer S. et al.

Olink Explore 3072/384GynecologyPathophysiologyPlasma

Nature Medicine, 2026
Low-dose oral nicotinamide mononucleotide for immune thrombocytopenia: a phase 1/2 trial

Li H., Xu Y., Chen Y. et al.

Olink Target 96HematologyPathophysiologyPlasma

BMC Medicine, 2026
Adherence to the EAT-Lancet Diet, plasma proteomics, and risk of venous thromboembolism: a large-scale prospective cohort study

He Q., Sun M., Wang Y. et al.

Olink Explore 3072/384CVDNutritional SciencePathophysiologyPlasma

Urogenital Tract Infection, 2026
Identification of Plasma Biomarker Signatures for Acute and Chronic Cystitis Using Olink Explore Proteomics in UK Biobank

Kang C., Kim S.

Olink Explore 3072/384UrologyPatient StratificationPlasma

BioData Mining, 2026
Divide-and-conquer analysis reveals hidden immune cell influencers across the placenta in preeclampsia

Paik H., Ko T., Park M. et al.

Olink Target 96Olink Target 48ObstetricsPathophysiologyPlasmaUrine

4146 publications